论文部分内容阅读
目的观察阿卡波糖治疗2型糖尿病餐后低血糖的临床效果。方法选择2013年8月-2015年8月医院收治的2型糖尿病患者155例,根据入院编号的偶数和奇数将其分为观察组78例和对照组77例,对照组给予二甲双胍治疗,观察组给予阿卡波糖治疗,对2组餐后2h血糖值(2h PBG)、空腹血糖值(FPG)、发生餐后低血糖次数以及不良反应发生率进行对比和分析。结果 2组在餐后低血糖发生率方面比较有统计学意义(P<0.05);治疗后,观察组2h PBG和FPG较对照组改善明显,差异有统计学意义(P<0.05);2组不良反应发生率比较有统计学意义(P<0.05)。结论临床上运用阿卡波糖对2型糖尿病餐后低血糖患者进行治疗,能够降低餐后低血糖发生率,使患者的血糖水平得到明显改善,是比较安全和有效的一种方法。
Objective To observe the clinical effect of acarbose on postprandial hypoglycemia in type 2 diabetic patients. Methods A total of 155 type 2 diabetic patients admitted from August 2013 to August 2015 in our hospital were divided into observation group (78 cases) and control group (77 cases) according to the even and odd numbers of admission numbers. The control group was treated with metformin, and the observation group The patients were given acarbose for treatment. The 2h PBG, FPG, the number of postprandial hypoglycemia and the incidence of adverse reactions were compared and analyzed. Results The incidence of postprandial hypoglycemia in the two groups was statistically significant (P <0.05). After treatment, PBG and FPG in the observation group improved significantly at 2h compared with the control group, the difference was statistically significant (P <0.05); Group 2 The incidence of adverse reactions was statistically significant (P <0.05). Conclusions The clinical application of acarbose in patients with type 2 diabetes postprandial hypoglycemia treatment can reduce the incidence of postprandial hypoglycemia, so that patients with significant improvement in blood glucose levels, is a safer and more effective method.